AETHLON MEDICAL INC (AEMD) Stock Analyst Earnings Estimates
NASDAQ:AEMD - Nasdaq - US00808Y4061 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 660K 1.54% | 290K -56.06% | 570K 96.55% | -100.00% | |||||
| EBITDA YoY % growth | -7.85M -33.05% | -10.3M -31.21% | -11.66M -13.20% | N/A -5.30% | N/A 26.69% | N/A | N/A | N/A | |
| EBIT YoY % growth | -7.89M -33.05% | -10.42M -32.07% | -11.9M -14.20% | -13.661M -6.19% | -9.489M 26.09% | -10.82M -15.85% | -14.819M -36.95% | -20.973M -41.53% | |
| Operating Margin | -1,195.45% | -3,593.10% | -2,087.72% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A 77.50% | -56.80 0.08% | -47.20 16.90% | -44.34 16.95% | -5.90 65.99% | -2.65 80.11% | -0.64 75.77% | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.88 67.75% | -0.39 75.35% | -0.52 49.98% | -0.93 88.35% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -2.063M 21.26% | -2.057M 29.11% | -2.117M -16.96% | -3.191M -59.53% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | -7.97 -9.48% | -1.03 | -6.94 | -673.64% |
| Q3 2025 Q2Q % growth | -1.04 90.51% | -1.74 | 0.70 | 40.26% |
| Q2 2025 Q2Q % growth | -1.60 83.61% | -1.59 | -0.01 | -0.55% |
| Q1 2025 Q2Q % growth | -2.72 75.71% | -2.57 | -0.15 | -5.82% |
| Q4 2024 Q2Q % growth | -7.28 9.00% | -10.04 | 2.76 | 27.47% |
| Q3 2024 Q2Q % growth | -10.96 -14.17% | -10.04 | -0.92 | -9.20% |
| Q2 2024 Q2Q % growth | -9.76 32.22% | -11.42 | 1.66 | 14.57% |
| Q1 2024 Q2Q % growth | -11.20 26.32% | -10.61 | -0.59 | -5.58% |
| Q4 2023 Q2Q % growth | -8.00 61.54% | -10.61 | 2.61 | 24.59% |
| Q3 2023 Q2Q % growth | -9.60 25.00% | -6.53 | -3.07 | -47.06% |
| Q2 2023 Q2Q % growth | -14.40 -38.46% | -17.54 | 3.14 | 17.92% |
| Q1 2023 Q2Q % growth | -15.20 -18.75% | -17.95 | 2.75 | 15.33% |
| Q4 2022 Q2Q % growth | -20.80 -73.33% | -11.42 | -9.38 | -82.07% |
| Q3 2022 Q2Q % growth | -12.80 20.00% | -10.61 | -2.19 | -20.66% |
| Q2 2022 Q2Q % growth | -10.40 13.33% | -12.24 | 1.84 | 15.03% |
| Q1 2022 Q2Q % growth | -12.80 | -10.61 | -2.19 | -20.66% |
| Q4 2021 Q2Q % growth | -12.00 31.19% | -16.05 | 4.05 | 25.23% |
| Q3 2021 Q2Q % growth | -16.00 33.33% | -13.46 | -2.54 | -18.84% |
| Q2 2021 Q2Q % growth | -12.00 88.37% | -9.79 | -2.21 | -22.55% |
| Q4 2020 Q2Q % growth | -17.44 83.85% | -13.06 | -4.38 | -33.58% |
| Q3 2020 Q2Q % growth | -24.00 81.82% | -84.05 | 60.05 | 71.44% |
| Q2 2020 Q2Q % growth | -103.20 -7.50% | -89.76 | -13.44 | -14.97% |
| Q1 2020 Q2Q % growth | -108.00 -50.00% | -97.92 | -10.08 | -10.29% |
| Q4 2019 Q2Q % growth | -108.00 | -85.68 | -22.32 | -26.05% |
| Q3 2019 Q2Q % growth | -132.00 | -85.68 | -46.32 | -54.06% |
| Q2 2019 Q2Q % growth | -96.00 | -85.68 | -10.32 | -12.04% |
| Q1 2019 Q2Q % growth | -72.00 | -97.92 | 25.92 | 26.47% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -100.00% | % | ||
| Q4 2023 Q2Q % growth | 574.25K 5,642.50% | 574.25K | % | |
| Q3 2023 Q2Q % growth | -100.00% | 3.235M | -3.235M | -100.00% |
| Q2 2023 Q2Q % growth | -100.00% | 70.89K | -70.89K | -100.00% |
| Q1 2023 Q2Q % growth | -100.00% | 70.89K | -70.89K | -100.00% |
| Q4 2022 Q2Q % growth | 10K -66.67% | 735.42K | -725.42K | -98.64% |
| Q3 2022 Q2Q % growth | 20K -96.77% | 261.12K | -241.12K | -92.34% |
| Q2 2022 Q2Q % growth | 130K | 192.78K | -62.78K | -32.57% |
| Q1 2022 Q2Q % growth | 130K | 204K | -74K | -36.27% |
| Q4 2021 Q2Q % growth | 30K -85.71% | 380.797K | -350.797K | -92.12% |
| Q3 2021 Q2Q % growth | 620K 51.22% | 102K | 518K | 507.84% |
| Q1 2021 Q2Q % growth | -100.00% | % | ||
| Q4 2020 Q2Q % growth | 210K 162.50% | 306K | -96K | -31.37% |
| Q3 2020 Q2Q % growth | 410K | 191.76K | 218.24K | 113.81% |
| Q2 2020 Q2Q % growth | 191.76K | -191.76K | -100.00% | |
| Q1 2020 Q2Q % growth | 30K -80.00% | 30K | % | |
| Q4 2019 Q2Q % growth | 80K | 51K | 29K | 56.86% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 23.21% | N/A | 33.67% | -430.61% |
| Revenue | N/A | N/A | N/A | N/A |